Journal Information
Vol. 37. Issue 6.
Pages 271-273 (June 2001)
Vol. 37. Issue 6.
Pages 271-273 (June 2001)
Full text access
El esputo inducido como procedimiento diagnóstico y de seguimiento en enfermedades respiratorias
Visits
23902
J. Belda*
Departament de Neumologia. Hospital de la Santa Creu i Sant Pau. Universitat Autónoma de Barcelona
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
L.M. Fabbri, S. Durham, S.T. Holgate, P.M. O'Byrne, D.S. Postma.
Assessment of airway inflammation: an overview.
Eur Respir J, 26 (1998), pp. 6S-8S
[2.]
W.Y. Yue, S.S. Cohen.
Sputum induction by newer inhalation methods in patients with pulmonary tuberculosis.
Dis Chest, 51 (1967), pp. 614-620
[3.]
J.M. Luce.
Sputum induction in the acquired immunodeficiency syndrome.
Am Rev Respir Dis, 133 (1986), pp. 513-514
[4.]
P.G. Gibson, A. Girgis-Gabardo, M.M. Morris, S. Mattoli, J.M. Kay, J. Dolovich, et al.
Cellular characteristics of sputum from patients with asthma and chronic bronchitis.
Thorax, 44 (1989), pp. 693-699
[5.]
I. Pin, P.G. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J.A. Denburg, F.E. Hargreave, et al.
Use of induced sputum cell counts to investigate airway inflammation in asthma.
Thorax, 47 (1992), pp. 25-29
[6.]
O. Holz, J. Kips, H. Magnussen.
Update on sputum methodology.
Eur Respir J, 16 (2000), pp. 355-359
[7.]
L. Jayaram, K. Parameswaran, M.R. Sears, F.E. Hargreave.
Induced sputum cell counts: their usefulness in clinical practice.
Eur Respir J, 16 (2000), pp. 150-158
[8.]
J. Belda, R. Leigh, K. Parameswaran, P.M. O'Byrne, M.R. Sears, F.E. Hargreave.
Induced sputum cell counts in healthy adults.
Am J Respir Crit Care Med, 161 (2000), pp. 475-478
[9.]
A. Spanevello, M. Confalonieri, F. Sulotto, F. Romano, G. Balzano, G.B. Migliori, et al.
Induced sputum cellularity. Reference values and distribution in normal volunteers.
Am J Respir Crit Care Med, 162 (2000), pp. 1172-1174
[10.]
J. Serra-Batlles, V. Plaza, E. Morejón, A. Comella, J. Brugues.
Costs of asthma according to the degree of severity.
Eur Respir J, 12 (1998), pp. 1322-1326
[11.]
R.M. Brown.
Treatment of chronic asthma with prednisone: significance of eosinophils in sputum.
Lancet, 2 (1958), pp. 1245-1247
[12.]
H.H. Wong, W. Fahy.
Safety of one method of sputum induction in asthmatic subjects.
Am Respir Crit Care Med, 155 (1997), pp. 299-303
[13.]
F.E. Hargreave.
Induced sputum and response to glucocorticosteroids.
J Allergy Clin Immunol, 102 (1998), pp. S102-S105
[14.]
D.M. Claman, H.A. Boushey, J. Liu, H. Wong, J.V. Fahy.
Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatics subjects.
J Allergy Clin Immunol, 93 (1994), pp. 861-869
[15.]
J.V. Fahy, H.A. Boushey.
Effect of low dose beclomethasone dipropionate on asthma control and airway inflammation.
Eur Respir J, 11 (1998), pp. 1240-1247
[16.]
M.O. Turner, P.R. Jonhston, E. Pizzichini, M.M.M. Pizzichini, P.A. Hussack, F.E. Hargreave.
Antiinflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.
Can Respir J, 54 (1998), pp. 108-114
[17.]
E. Pizzichini, L.J. Clelland, A. Efthimiadis, J. Mahony, J. Dolovich, F.E. Hargreave.
Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment.
Am J Respir Crit Care Med, 155 (1997), pp. 1501-1508
[18.]
I.D. Pavord, C.E. Brightling, G. Woltmann, A.J. Wardlaw.
Non-eosinophilic corticosteroid unresponsive asthma.
Lancet, 353 (1999), pp. 2213-2214
[19.]
K. Parameswaran, R. Leigh, F.E. Hargreave.
Sputum eosinophilia count to assess compliance with corticosteroid therapy in asthma.
J Allergy Clin Immunol, 104 (1999), pp. 502-503
[20.]
A.G. Wong, I. Pavord, M.R. Sears, F.E. Hargreave.
A case for serial examination of sputum inflamatory cells.
Eur Respir J, 9 (1996), pp. 2174-2175
[21.]
F.E. Hargreave, R. Leigh.
Induced sputum, eosinophilic bronchitis and COPD.
Am J Respir Crit Care Med, 160 (1999), pp. 553-557
[22.]
M.M. Pizzichini, E. Pizzichini, K. Parameswaran, L. Clellanol, A. Efthimiadis, J. Dolovich, et al.
Non-asthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia.
Can Respir J, 6 (1999), pp. 323-330
[23.]
R.a. McIvor, E. Pizzichini, M.O. Turner, P.A. Hussack, F.E. Hargreave, M.R. Sears.
Potential masking effects of salmeterol on airway inflammation.
Am J Respir Crit Care Med, 157 (1998), pp. 924-930
[24.]
E. Pizzichini, J.A. Leff, T.F. Reiss, L. Hendeles, L.P. Goulet, L.X. Wei, et al.
Montelukast reduces airway eosinophilic inflammation in asthma: a randomised, controlled trial.
Eur Respir J, 14 (1999), pp. 12-18
[25.]
V.M. Keatings, P.J. Barnes.
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects.
Am Respir J Crit Care Med, 155 (1997), pp. 449-453
[26.]
V.M. Keatings, A. Jatakanon, Y.M. Worsdell, P.J. Barnes.
Effects of inhaled and oral glucocorticosteroids on inflammatory indices in asthma and COPD.
Am J Respir Crit Care Med, 155 (1997), pp. 541-548
[27.]
M. Saetta, A. Stefano, P. Maestrelli, G. Turato, A. Roggeri.
Airway eosinophilia in chronic bronchitis during exacerbations.
Am J Respir Crit Care Med, 150 (1994), pp. 1646-1652
[28.]
K. Fujimoto, K. Kubo, H. Yamamoto, S. Yamaguchi, Y. Matsuzawa.
Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary enphysema.
Chest, 115 (1999), pp. 697-702
[29.]
E. Pizzichini, M.M.M. Pizzichini, P. Gibson, K. Parameswaran, G.J. Gleich, L. Berman, et al.
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.
Am J Respir Crit Care Med, 158 (1998), pp. 1-7
[30.]
C.E. Brightling, W. Monteiro, R. Ward, D. Parker, M.D. Morgan, A.J. Wardlaw, et al.
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease; a randomised controlled trial.
Lancet, 356 (2000), pp. 1480-1485
[31.]
K. Fujimoto, K. Kubo, H. Yamamoto, S. Yamaguchi, Y. Matsuzawa.
Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary enphysema.
Chest, 115 (1999), pp. 697-702
[32.]
P. Venge, J. Bystrom, M. Carlson, L. Hakansson, M. Karawacjzyk, C. Peterson, et al.
Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease.
Clin Exp Allergy, 29 (1999), pp. 1172-1186
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica